ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,848.35
      -0.10%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Seelos Therapeutics Inc (SEEL)

      7. Seelos Therapeutics Inc (SEEL) Financials

      Seelos Therapeutics Inc

      Seelos Therapeutics Inc (SEEL)

      NASDAQ
      0.44
      -0.0311
      (-6.60%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      0.45
      0.01
      (2.27%)
      After Hours: 7:21PM
      Delayed by 15 minutes

      Seelos Therapeutics Inc Financial Summary

      The current SEEL market cap is 977.89k. The company's latest EPS is USD -17.4324 and P/E is -0.03.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 808k336k406k653k579k
      Operating Income -8.93M-10.95M-12.6M-8.01M-6.06M
      Net Income -13.43M-29.5M10.5M-5.45M-2.66M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 375k0002.2M
      Operating Income -29.75M-18.76M-61.67M-70.92M-40.5M
      Net Income -51.26M-19.1M-66.05M-73.53M-37.88M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 23.64M11.89M6.22M5.42M3.61M
      Total Liabilities 44.3M59.07M36.63M38.93M36.72M
      Total Equity -20.66M-47.18M-30.41M-33.51M-33.1M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 11.1M17.49M83.5M22.75M5.42M
      Total Liabilities 11.1M14.92M26.18M33.36M38.93M
      Total Equity -7k2.57M57.32M-10.61M-33.51M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.35M-16.25M-22M-23.91M-4.64M
      Investing N/A N/A N/A N/A N/A
      Financing 8.87M6.56M9.05M11.38M2.17M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -19.31M-20.91M-49M-61.6M-23.91M
      Investing N/A N/A N/A N/A N/A
      Financing 29.52M26.31M112.07M-1.6M11.38M

      Stats and Ratios

      Market Cap 977.89k
      Price to Earnings Ratio -0.03
      Price to Sales Ratio 0.43
      Price to Cash Ratio 0.32
      Price to Book Ratio -0.03
      Dividend Yield -

      Share Statistics

      Shares Outstanding 2.17M
      Average Volume (1 week) 298.31k
      Average Volume (1 Month) 1.36M
      52 Week Change -99.85%
      52 Week High 398.40
      52 Week Low 0.43
      Spread (Intraday) 0.01 (2.89%)

      Company Info

      Company Name Seelos Therapeutics Inc
      Address 701 s carson st
      carson city, nevada 89701
      Website https://seelostherapeutics.com
      Industry pharmaceutical preparations (2834)